Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Bevacizumab|DRUG: Docetaxel|DRUG: Gemcitabine
Sponsor: University Hospital of Crete